Tazarotene
CAS 118292-40-3 8 FDA-DMF suppliersSmall Molecule
Overview
Tazarotene is a third-generation prescription topical retinoid used for the treatment of psoriasis, acne, and sun-damaged skin. It works by modulating skin cell growth and reducing inflammation.
API suppliers (7)
Suppliers of Tazarotene backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- ALIVUS LIFE SCIENCES LTD1 active DMF
- ALIVUS LIFE SCIENCES LTD1 active DMF
- ALIVUS LIFE SCIENCES LTD1 active DMF
- PCASFrance1 active DMF
- BASF SEGermany
- Piramal Healthcare UK Ltd.United Kingdom
- WATSON PHARMA PRIVATE LTD
Patent & exclusivity (US)
Per the FDA Orange Book (18 approved US products), the latest listed US patent on Tazarotene expires 10 May 2038. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
DermatologyPsoriasisAcne
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.